Clinical trial
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
NCT05302817 is registered in ClinicalTrials.gov with Xemed LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
- Lead sponsor
- Xemed LLC
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 17, 2023
- Completion date
- February 28, 2025
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.